Literature DB >> 2701363

Private and public autocrine loops in neoplastic cells.

T M Browder1, C E Dunbar, A W Nienhuis.   

Abstract

Autocrine growth factor loops ensure the continued growth of neoplastic cells. According to the traditional view of such autocrine loops, receptor binding and transduction of a mitogenic signal occur when a growth factor is secreted and subsequently interacts with its receptor on the surface of the secreting or neighboring cells. For several growth factors there is now evidence that the mitogenic signal may be transduced without factor secretion. In these instances, the growth factor appears to interact with its receptor intracellularly, creating in effect a "private" autocrine loop. We will discuss three growth factors that may operate by the latter mechanism, as well as two that rely instead on classical "public" autocrine loops, where the growth factor must be secreted and is therefore accessible to neighboring cells. We also consider the properties of these growth factor/receptor systems that may determine their involvement in either type of autocrine loop.

Mesh:

Substances:

Year:  1989        PMID: 2701363

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  18 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650.

Authors:  B M Carey; M Dooley; R Weedle; M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

3.  Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.

Authors:  A Yayon; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Transformed phenotype conferred to NIH/3T3 cells by ectopic expression of heparin-binding growth factor 1/acidic fibroblast growth factor.

Authors:  P Bunnag; K S Waddell; M L Varban; I M Chiu
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

5.  Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.

Authors:  A Kasza; K Rogowski; W Kilarski; R Sobota; T Bernas; J Dobrucki; J Travis; A Koj; M Bugno; T Kordula
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

6.  Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor.

Authors:  H Pratsinis; A Saetta; S Gagos; P Davaris
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

Review 7.  Growth factors and tyrosine protein kinases in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

8.  The role of growth regulatory aberrations in progression of human colon carcinoma.

Authors:  G M Howell; L Sun; B L Ziober; S P Wu; M G Brattain
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

Review 9.  Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.

Authors:  R S Kerbel
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

Review 10.  Autocrine growth factors and solid tumor malignancy.

Authors:  J H Walsh; W E Karnes; F Cuttitta; A Walker
Journal:  West J Med       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.